China Resources Pharmaceutical Group Limited (HKG:3320)
4.760
+0.030 (0.63%)
Sep 29, 2025, 4:08 PM HKT
HKG:3320 Market Cap
HKG:3320 has a market cap or net worth of 29.90 billion as of September 29, 2025. Its market cap has decreased by -8.81% in one year.
Market Cap
29.90B
Enterprise Value
154.34B
Revenue
285.94B
Ranking
n/a
PE Ratio
9.75
Stock Price
4.76
Market Cap Chart
Since October 28, 2016, HKG:3320's market cap has decreased from 55.61B to 29.90B, a decrease of -46.23%. That is a compound annual growth rate of -6.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 29, 2025 | 29.90B | -16.49% |
Dec 31, 2024 | 35.81B | 11.11% |
Dec 29, 2023 | 32.23B | -18.83% |
Dec 30, 2022 | 39.71B | 78.03% |
Dec 31, 2021 | 22.30B | -10.80% |
Dec 31, 2020 | 25.00B | -44.97% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 279.26B |
Hansoh Pharmaceutical Group Company | 210.92B |
JD Health International | 206.50B |
Innovent Biologics | 159.71B |
WuXi Biologics | 158.73B |
Sino Biopharmaceutical | 142.12B |
Akeso | 122.24B |
Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |